MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration
Value
Estimated€500,000 · 500,000 EUR
Awarded—
CPV codes
73200000 Research & development servicesDescription
Regulation (EU) 2023/1322, which establishes the European Union Drugs Agency (EUDA), strengthens the Union’s preparedness for, and response to, drug-related health and security challenges. Article 15 in particular provides for a dedicated network of forensic and toxicology laboratories to enhance analytical capacity, harmonise methods, support quality assurance and facilitate the exchange of data and expertise across Member States. This strengthens and supports the timely detection, assessment and response to drug-related risks. Within this policy context, systematic investigation of drug metabolism is a cornerstone of clinical and forensic toxicology. Overall, the objective of this contract is to reinforce collective capacity across the EU to interpret toxicological findings and, critically, to improve the detection, identification, and timely reporting of exposure to NPS and other illicit drugs. By generating robust metabolic, pharmacological, and analytical data, and by consolidating these outputs into a centralised, accessible EU database, the project aims to strengthen timely reporting, harmonise practices, and ensure that toxicological evidence can be translated more effectively into monitoring, early warning, and public health responses to emerging NPS threats.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-22 | MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration | European Union Drugs Agency PT | 100% |
| 2026-10-07 | Framework contract for EUDA scientific studies support services | European Union Drugs Agency PT | 90% |
| 2026-08-25 | Services related to tabletop exercises in the fields of physical security, crisis management, and business continuity. | European Medicines Agency, MED - European Medicines Agency NL | 88% |
| 2026-08-27 | Reference substances for forensic medicine to Oslo University Hospital. | SYKEHUSINNKJØP HF NO | 88% |
| 2026-09-08 | Test for amino acids in plasma and urine | HUS Group FI | 87% |
| 2026-08-06 | Supply of a mass spectrometry analyzer for newborn screening and services of related maintenance | Laboratoire National de Santé LU | 87% |